[Internet and amyotrophic lateral sclerosis treatment: What is wrong?]

Authors :: Meininger, V.
Antoine, J.-C.
Arne-Bes, M. C.
Broussolle, E.
Bruneteau, G.
Camdessanche, J. P.
Camu, W.
Carluer, L.
Cintas, P.
Clavelou, Pierre
Corcia, P.
Couratier, Philippe
Danel-Brunaud, V.
Desnuelle, C.
Destée, A.
Dib, M.
Fleury, M.-C.
Furby, A.
Giroud, M.
Gonzales, J.
Guy, N.
Kolev, I.
Lacomblez, Lucette
Lardillier-Noel, D.
Le Forestier, N.
Maugin, D.
Nicolas, G.
Pittion, S.
Pouget, Jean
Pradat, P. F.
Rousso, E.
Salachas, F.
Soriani, M. H.
Tranchant, C.
Vandenberghe, N.
Verschueren, A.
Viader, F.
Vial, C.
Service de Neurologie [CHU Limoges]
CHU Limoges
Neuroépidémiologie Tropicale et Comparée (NETEC)
Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST FR CNRS 3503)-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Université de Limoges (UNILIM)
Source :: Revue Neurologique, Revue Neurologique, Elsevier Masson, 2009, 165 (3), pp.207-10. ⟨10.1016/j.neurol.2009.01.003⟩
Publication Year :: 2009
Publisher :: HAL CCSD, 2009.
Abstract: International audience

Subjects :: Internet
United States Food and Drug Administration
Amyotrophic Lateral Sclerosis
Drug Evaluation, Preclinical
Lithium Compounds
Humans
Intercellular Signaling Peptides and Proteins
[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologie
France
Insulin-Like Growth Factor I
Drug Approval
United States
ComputingMilieux_MISCELLANEOUS

Language :: French
ISSN :: 00353787
Database :: OpenAIRE
Journal :: Revue Neurologique, Revue Neurologique, Elsevier Masson, 2009, 165 (3), pp.207-10. ⟨10.1016/j.neurol.2009.01.003⟩
Accession number :: edsair.pmid.dedup....77d4a9c6b35387a0f56d9f356aea1b40
Full Text :: https://doi.org/10.1016/j.neurol.2009.01.003⟩